<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title>Critical Care</journal-title><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19239703</article-id><article-id pub-id-type="pmc">2688140</article-id><article-id pub-id-type="publisher-id">cc7725</article-id><article-id pub-id-type="doi">10.1186/cc7725</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Efficacy of positive end-expiratory pressure titration after the alveolar recruitment manoeuvre in patients with acute respiratory distress syndrome</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Huh</surname><given-names>Jin Won</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jwhuh@paik.ac.kr</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Jung</surname><given-names>Hoon</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>geny2000@paik.ac.kr</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Choi</surname><given-names>Hye Sook</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>respichoi@dongguk.ac.kr</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Hong</surname><given-names>Sang-Bum</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>sbhong@amc.seoul.kr</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Lim</surname><given-names>Chae-Man</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>cmlim@amc.seoul.kr</email></contrib><contrib id="A6" corresp="yes" contrib-type="author"><name><surname>Koh</surname><given-names>Younsuck</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>yskoh@amc.seoul.kr</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Pulmonary and Critical Care Medicine, Inje University Ilsan Paik Hospital, Daehwa-dong, Goyang-si, 411-706, Korea</aff><aff id="I2"><label>2</label>Department of Pulmonary and Critical Care Medicine, Dongguk University, College of Medicine, Seokjang-dong, Gyeongju-si, 780-714, Korea</aff><aff id="I3"><label>3</label>Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap-dong, Seoul 138-736, Korea</aff><pub-date pub-type="ppub"><year>2009</year></pub-date><pub-date pub-type="epub"><day>24</day><month>2</month><year>2009</year></pub-date><volume>13</volume><issue>1</issue><fpage>R22</fpage><lpage>R22</lpage><ext-link ext-link-type="uri" xlink:href="http://ccforum.com/content/13/1/R22"></ext-link><history><date date-type="received"><day>3</day><month>11</month><year>2008</year></date><date date-type="rev-request"><day>10</day><month>12</month><year>2008</year></date><date date-type="rev-recd"><day>14</day><month>1</month><year>2009</year></date><date date-type="accepted"><day>24</day><month>2</month><year>2009</year></date></history><permissions><copyright-statement>Copyright © 2009 Huh et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Huh et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title><offsets xml_i="3974" xml_f="3986" txt_i="11" txt_f="23">Introduction</offsets></title><p><offsets xml_i="3997" xml_f="4383" txt_i="24" txt_f="410">In acute respiratory distress syndrome (ARDS), adequate positive end-expiratory pressure (PEEP) may decrease ventilator-induced lung injury by minimising overinflation and cyclic recruitment-derecruitment of the lung. We evaluated whether setting the PEEP using decremental PEEP titration after an alveolar recruitment manoeuvre (ARM) affects the clinical outcome in patients with ARDS.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="4424" xml_f="4431" txt_i="412" txt_f="419">Methods</offsets></title><p><offsets xml_i="4442" xml_f="4640" txt_i="420" txt_f="618">Fifty-seven patients with early ARDS were randomly assigned to a group given decremental PEEP titration following ARM or a table-based PEEP (control) group. PEEP and inspired fraction of oxygen (FiO</offsets><sub><offsets xml_i="4645" xml_f="4646" txt_i="618" txt_f="619">2</offsets></sub><offsets xml_i="4652" xml_f="4732" txt_i="619" txt_f="699">) in the control group were set according to the table-based combinations of FiO</offsets><sub><offsets xml_i="4737" xml_f="4739" txt_i="699" txt_f="701">2 </offsets></sub><offsets xml_i="4745" xml_f="5167" txt_i="701" txt_f="1123">and PEEP of the ARDS network, by which we aimed to achieve a PEEP level compatible with an oxygenation target. In the decremental PEEP titration group, the oxygen saturation and static compliance were monitored as the patients performed the ARM along with the extended sigh method, which is designed to gradually apply and withdraw a high distending pressure over a prolonged period, and the decremental titration of PEEP.</offsets></p></sec><sec><title><offsets xml_i="5189" xml_f="5196" txt_i="1125" txt_f="1132">Results</offsets></title><p><offsets xml_i="5207" xml_f="5752" txt_i="1133" txt_f="1678">The baseline characteristics did not differ significantly between the control and decremental PEEP titration groups. Initial oxygenation improved more in the decremental PEEP titration group than in the control group. However, dynamic compliance, tidal volume and PEEP were similar in the two groups during the first week. The duration of use of paralysing or sedative agents, mechanical ventilation, stay in the intensive care unit and mortality at 28 days did not differ significantly between the decremental PEEP titration and control groups.</offsets></p></sec><sec><title><offsets xml_i="5774" xml_f="5785" txt_i="1680" txt_f="1691">Conclusions</offsets></title><p><offsets xml_i="5796" xml_f="6046" txt_i="1692" txt_f="1942">The daily decremental PEEP titration after ARM showed only initial oxygenation improvement compared with the table-based PEEP method. Respiratory mechanics and patient outcomes did not differ between the decremental PEEP titration and control groups.</offsets></p></sec><sec><title><offsets xml_i="6068" xml_f="6086" txt_i="1944" txt_f="1962">Trial registration</offsets></title><p><offsets xml_i="6097" xml_f="6143" txt_i="1963" txt_f="2009">ClinicalTrials.gov identifier: ISRCTN79027921.</offsets></p></sec></abstract></article-meta><notes><p>See related commentary by Suarez-Sipmann and Bohm, <ext-link ext-link-type="uri" xlink:href="http://ccforum.com/content/13/3/134"></ext-link></p></notes></front><body><sec><title><offsets xml_i="6368" xml_f="6380" txt_i="2018" txt_f="2030">Introduction</offsets></title><p><offsets xml_i="6391" xml_f="6614" txt_i="2031" txt_f="2254">Two recent randomised controlled trials involving patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) demonstrated that mortality can be reduced significantly by setting a low tidal volume (V</offsets><sub><offsets xml_i="6619" xml_f="6620" txt_i="2254" txt_f="2255">T</offsets></sub><offsets xml_i="6626" xml_f="6629" txt_i="2255" txt_f="2258">) [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="6660" xml_f="6661" txt_i="2258" txt_f="2259">1</offsets></xref><offsets xml_i="6668" xml_f="6697" txt_i="2259" txt_f="2288">] and by setting both a low V</offsets><sub><offsets xml_i="6702" xml_f="6704" txt_i="2288" txt_f="2290">T </offsets></sub><offsets xml_i="6710" xml_f="6806" txt_i="2290" txt_f="2386">and adequate positive end-expiratory pressure (PEEP) levels titrated by pressure-volume curves [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="6837" xml_f="6838" txt_i="2386" txt_f="2387">2</offsets></xref><offsets xml_i="6845" xml_f="6846" txt_i="2387" txt_f="2388">,</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="6877" xml_f="6878" txt_i="2388" txt_f="2389">3</offsets></xref><offsets xml_i="6885" xml_f="7024" txt_i="2389" txt_f="2528">]. However, this strategy favours further lung collapse or derecruitment, especially when used with a high inspired fraction of oxygen (FiO</offsets><sub><offsets xml_i="7029" xml_f="7030" txt_i="2528" txt_f="2529">2</offsets></sub><offsets xml_i="7036" xml_f="7039" txt_i="2529" txt_f="2532">) [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="7070" xml_f="7071" txt_i="2532" txt_f="2533">4</offsets></xref><offsets xml_i="7078" xml_f="7246" txt_i="2533" txt_f="2701">]. The importance of opening the lung and keeping it open seems increasingly significant in this era of lung-protective ventilatory support because the use of a small V</offsets><sub><offsets xml_i="7251" xml_f="7253" txt_i="2701" txt_f="2703">T </offsets></sub><offsets xml_i="7259" xml_f="7482" txt_i="2703" txt_f="2926">for this strategy may worsen progressive lung collapse. Moreover, the alveolar and systemic inflammatory responses can be attenuated by minimising overinflation and cyclic recruitment–derecruitment of the lung by reducing V</offsets><sub><offsets xml_i="7487" xml_f="7489" txt_i="2926" txt_f="2928">T </offsets></sub><offsets xml_i="7495" xml_f="7524" txt_i="2928" txt_f="2957">and increasing PEEP in ARDS [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="7555" xml_f="7556" txt_i="2957" txt_f="2958">5</offsets></xref><offsets xml_i="7563" xml_f="7565" txt_i="2958" txt_f="2960">].</offsets></p><p><offsets xml_i="7572" xml_f="7681" txt_i="2961" txt_f="3070">The best method of setting optimal PEEP after recruitment to prevent recollapse is still a matter of debate [</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="7712" xml_f="7713" txt_i="3070" txt_f="3071">6</offsets></xref><offsets xml_i="7720" xml_f="7878" txt_i="3071" txt_f="3229">]. In the ALVEOLI study, mortality rates and the number of ventilator-free days did not differ significantly between the lower- and higher-PEEP study groups [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="7909" xml_f="7910" txt_i="3229" txt_f="3230">7</offsets></xref><offsets xml_i="7917" xml_f="8001" txt_i="3230" txt_f="3314">]. This result may have reflected the use of the same PEEP level (combination of FiO</offsets><sub><offsets xml_i="8006" xml_f="8008" txt_i="3314" txt_f="3316">2 </offsets></sub><offsets xml_i="8014" xml_f="8414" txt_i="3316" txt_f="3716">and PEEP) for the heterogeneous patient group and an inappropriately high PEEP in the nonrecruiters, which may have resulted in overdistension. Gattinoni and colleagues reported that the percentage of potentially recruitable lung tissue may be different in patients with ARDS and that the use of a higher PEEP level in patients with a lower percentage of potentially recruitable lung may be harmful [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="8445" xml_f="8446" txt_i="3716" txt_f="3717">8</offsets></xref><offsets xml_i="8453" xml_f="8783" txt_i="3717" txt_f="4047">]. These studies did not evaluate completely the effect of using individualised PEEP on the survival rate of patients with ARDS. The higher PEEP levels should be adjusted according to individual lung morphology. However, the strategies for setting PEEP using a plateau pressure or recruitment manoeuvre do not decrease mortality [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="8814" xml_f="8815" txt_i="4047" txt_f="4048">9</offsets></xref><offsets xml_i="8822" xml_f="8823" txt_i="4048" txt_f="4049">,</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="8855" xml_f="8857" txt_i="4049" txt_f="4051">10</offsets></xref><offsets xml_i="8864" xml_f="8866" txt_i="4051" txt_f="4053">].</offsets></p><p><offsets xml_i="8873" xml_f="9079" txt_i="4054" txt_f="4260">We designed an individual PEEP strategy using decremental PEEP titration after an alveolar recruitment manoeuvre (ARM) for each patient with ARDS. An ARM is a way to standardise the history of lung volume [</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="9111" xml_f="9113" txt_i="4260" txt_f="4262">11</offsets></xref><offsets xml_i="9120" xml_f="9359" txt_i="4262" txt_f="4501">]. The objective of this study was to evaluate whether setting the PEEP using decremental PEEP titration after ARM affects the oxygenation and outcome of patients in the early stage of ARDS compared with the table-based combinations of FiO</offsets><sub><offsets xml_i="9364" xml_f="9366" txt_i="4501" txt_f="4503">2 </offsets></sub><offsets xml_i="9372" xml_f="9402" txt_i="4503" txt_f="4533">and PEEP in the ARDS network [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="9433" xml_f="9434" txt_i="4533" txt_f="4534">1</offsets></xref><offsets xml_i="9441" xml_f="9443" txt_i="4534" txt_f="4536">].</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="9494" xml_f="9515" txt_i="4538" txt_f="4559">Materials and methods</offsets></title><sec><title><offsets xml_i="9535" xml_f="9551" txt_i="4560" txt_f="4576">Study population</offsets></title><p><offsets xml_i="9562" xml_f="9956" txt_i="4577" txt_f="4971">Fifty-seven consecutive patients (35 men and 22 women) admitted to the medical intensive care unit (MICU) of Asan Medical Center, in Seoul, Korea, who were diagnosed with ARDS of various aetiologies were enrolled in the study between July 2004 and September 2006. Patient selection for the study was based on the criteria of ARDS proposed by the American–European Consensus Conference on ARDS [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="9988" xml_f="9990" txt_i="4971" txt_f="4973">12</offsets></xref><offsets xml_i="9997" xml_f="10077" txt_i="4973" txt_f="5053">]: acute onset, presence of hypoxaemia (partial arterial pressure of oxygen (PaO</offsets><sub><offsets xml_i="10082" xml_f="10083" txt_i="5053" txt_f="5054">2</offsets></sub><offsets xml_i="10089" xml_f="10094" txt_i="5054" txt_f="5059">)/FiO</offsets><sub><offsets xml_i="10099" xml_f="10101" txt_i="5059" txt_f="5061">2 </offsets></sub><offsets xml_i="10107" xml_f="10321" txt_i="5061" txt_f="5275">(PF ratio) ≤ 200 mmHg regardless of the PEEP level), bilateral and diffuse opacities seen on frontal chest x-ray and absence of left ventricular failure with pulmonary arterial occluded pressure of 18 mmHg of less.</offsets></p><p><offsets xml_i="10328" xml_f="10481" txt_i="5276" txt_f="5429">The study protocol was approved by the institutional board of the ethics committee and written informed consent was obtained from the patients' families.</offsets></p></sec><sec><title><offsets xml_i="10503" xml_f="10524" txt_i="5431" txt_f="5452">Ventilator procedures</offsets></title><p><offsets xml_i="10535" xml_f="10666" txt_i="5453" txt_f="5584">Patients were given ventilatory support primarily in the supine position and ventilated according to the ARDS network strategy. FiO</offsets><sub><offsets xml_i="10671" xml_f="10672" txt_i="5584" txt_f="5585">2</offsets></sub><offsets xml_i="10678" xml_f="10760" txt_i="5585" txt_f="5667">, PEEP and respiratory rate were set to achieve an arterial oxygen saturation (SaO</offsets><sub><offsets xml_i="10765" xml_f="10766" txt_i="5667" txt_f="5668">2</offsets></sub><offsets xml_i="10772" xml_f="10797" txt_i="5668" txt_f="5693">) of between 88 and 92% [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="10828" xml_f="10829" txt_i="5693" txt_f="5694">2</offsets></xref><offsets xml_i="10836" xml_f="10851" txt_i="5694" txt_f="5709">]. The target V</offsets><sub><offsets xml_i="10856" xml_f="10858" txt_i="5709" txt_f="5711">T </offsets></sub><offsets xml_i="10864" xml_f="10945" txt_i="5711" txt_f="5792">was 6 ml/kg of predicted body weight, with allowances of up to 8 ml/kg if the SaO</offsets><sub><offsets xml_i="10950" xml_f="10952" txt_i="5792" txt_f="5794">2 </offsets></sub><offsets xml_i="10958" xml_f="11207" txt_i="5794" txt_f="6043">were below 88% or less than 7.2 of arterial pH by severe hypercapnoea. The patients were randomly assigned with the use of a randomisation scheme to either the decremental PEEP titration group or the control (table-based PEEP setting) group (Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="11237" xml_f="11238" txt_i="6043" txt_f="6044">1</offsets></xref><offsets xml_i="11245" xml_f="11247" txt_i="6044" txt_f="6046">).</offsets></p><fig position="float" id="F1"><label><offsets xml_i="11288" xml_f="11296" txt_i="6047" txt_f="6055">Figure 1</offsets></label><caption><p><offsets xml_i="11316" xml_f="11501" txt_i="6055" txt_f="6240">Study groups of patients. Four patients who withdrew from the study were excluded from the analysis. ARDS = acute respiratory distress syndrome; PEEP = positive end-expiratory pressure.</offsets></p></caption><graphic xlink:href="cc7725-1"></graphic></fig></sec><sec><title><offsets xml_i="11580" xml_f="11593" txt_i="6242" txt_f="6255">Patient group</offsets></title><sec><title><offsets xml_i="11613" xml_f="11653" txt_i="6256" txt_f="6296">Table-based PEEP setting (control) group</offsets></title><p><offsets xml_i="11664" xml_f="11671" txt_i="6297" txt_f="6304">The FiO</offsets><sub><offsets xml_i="11676" xml_f="11677" txt_i="6304" txt_f="6305">2</offsets></sub><offsets xml_i="11683" xml_f="11753" txt_i="6305" txt_f="6375">-PEEP strategy has been used in previous ARDS Network studies (Figure </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="11783" xml_f="11784" txt_i="6375" txt_f="6376">2</offsets></xref><offsets xml_i="11791" xml_f="11806" txt_i="6376" txt_f="6391">). PEEP and FiO</offsets><sub><offsets xml_i="11811" xml_f="11813" txt_i="6391" txt_f="6393">2 </offsets></sub><offsets xml_i="11819" xml_f="11875" txt_i="6393" txt_f="6449">were set according to the table of lower PEEP/higher FiO</offsets><sub><offsets xml_i="11880" xml_f="11882" txt_i="6449" txt_f="6451">2 </offsets></sub><offsets xml_i="11888" xml_f="12033" txt_i="6451" txt_f="6596">combinations (the lower PEEP strategy of the ALVEOLI study), with the goal of obtaining a lower PEEP level compatible with an oxygenation target.</offsets></p><fig position="float" id="F2"><label><offsets xml_i="12074" xml_f="12082" txt_i="6597" txt_f="6605">Figure 2</offsets></label><caption><p><offsets xml_i="12102" xml_f="12118" txt_i="6605" txt_f="6621">Study protocol. </offsets><bold><offsets xml_i="12124" xml_f="12128" txt_i="6621" txt_f="6625">(a) </offsets></bold><offsets xml_i="12135" xml_f="12212" txt_i="6625" txt_f="6702">Table-based positive end-expiratory pressure (PEEP) setting (control) group. </offsets><bold><offsets xml_i="12218" xml_f="12222" txt_i="6702" txt_f="6706">(b) </offsets></bold><offsets xml_i="12229" xml_f="12309" txt_i="6706" txt_f="6786">Decremental PEEP titration group after alveolar recruitment manoeuvre (ARM). FiO</offsets><sub><offsets xml_i="12314" xml_f="12316" txt_i="6786" txt_f="6788">2 </offsets></sub><offsets xml_i="12322" xml_f="12352" txt_i="6788" txt_f="6818">= inspired fracture of oxygen.</offsets></p></caption><graphic xlink:href="cc7725-2"></graphic></fig></sec><sec><title><offsets xml_i="12431" xml_f="12463" txt_i="6820" txt_f="6852">Decremental PEEP titration group</offsets></title><p><offsets xml_i="12474" xml_f="12802" txt_i="6853" txt_f="7181">The ARM was performed immediately after enrollment in the study and was applied once a day usually in the morning for one week. The ventilatory circuit was not disconnected after ARM to avoid lung derecruitment. The ARM was also repeated when the ventilatory circuit was disconnected (incidentally or for bronchoscope) or if FiO</offsets><sub><offsets xml_i="12807" xml_f="12809" txt_i="7181" txt_f="7183">2 </offsets></sub><offsets xml_i="12815" xml_f="13235" txt_i="7183" txt_f="7603">requirement was increasing again in the patient, who showed initial improvement of oxygenation by ARM. If the weaning trial was performed within one week, the ARM was stopped earlier than the usual schedule. During the ARM, all patients were sedated and paralysed by continuous infusion of midazolam-ketamine and vecuronium bromide. No changes were made in the doses of inotropic agents or fluid infusion during the ARM.</offsets></p><p><offsets xml_i="13242" xml_f="13471" txt_i="7604" txt_f="7833">The ARM used the extended sigh method, which is designed to gradually apply and withdraw a high distending pressure over a prolonged period. It takes about 15 to 20 minutes for two cycles of ARM according to our protocol (Figure </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="13501" xml_f="13502" txt_i="7833" txt_f="7834">2</offsets></xref><offsets xml_i="13509" xml_f="13512" txt_i="7834" txt_f="7837">) [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="13544" xml_f="13546" txt_i="7837" txt_f="7839">13</offsets></xref><offsets xml_i="13553" xml_f="13717" txt_i="7839" txt_f="8003">]. We changed the ventilatory mode from pressure-controlled mode to the volume-controlled mode during ARM. The distending pressure was determined by the delivered V</offsets><sub><offsets xml_i="13722" xml_f="13723" txt_i="8003" txt_f="8004">T</offsets></sub><offsets xml_i="13729" xml_f="13845" txt_i="8004" txt_f="8120">, PEEP increment and the pause time (0.5 seconds). During the ARM, PEEP was added from baseline to 15, 20 and 25 cmH</offsets><sub><offsets xml_i="13850" xml_f="13851" txt_i="8120" txt_f="8121">2</offsets></sub><offsets xml_i="13857" xml_f="13925" txt_i="8121" txt_f="8189">O sequentially (every 30 seconds from the baseline PEEP until 25 cmH</offsets><sub><offsets xml_i="13930" xml_f="13931" txt_i="8189" txt_f="8190">2</offsets></sub><offsets xml_i="13937" xml_f="13946" txt_i="8190" txt_f="8199">O). The V</offsets><sub><offsets xml_i="13951" xml_f="13953" txt_i="8199" txt_f="8201">T </offsets></sub><offsets xml_i="13959" xml_f="13999" txt_i="8201" txt_f="8241">was decreased by 25% from the baseline V</offsets><sub><offsets xml_i="14004" xml_f="14006" txt_i="8241" txt_f="8243">T </offsets></sub><offsets xml_i="14012" xml_f="14208" txt_i="8243" txt_f="8439">during the incremental PEEP trial phase, and then returned to baseline levels during the decremental PEEP trial phase. Therefore, the distending pressures were changed depending on the patient's V</offsets><sub><offsets xml_i="14213" xml_f="14215" txt_i="8439" txt_f="8441">T </offsets></sub><offsets xml_i="14221" xml_f="14310" txt_i="8441" txt_f="8530">and lung mechanics. However, we did not allow the peak airway pressure to go above 55 cmH</offsets><sub><offsets xml_i="14315" xml_f="14316" txt_i="8530" txt_f="8531">2</offsets></sub><offsets xml_i="14322" xml_f="14464" txt_i="8531" txt_f="8673">O during the ARM. The decremental PEEP titration at the second cycle of ARM was performed with progressive decreases in PEEP in steps of 1 cmH</offsets><sub><offsets xml_i="14469" xml_f="14470" txt_i="8673" txt_f="8674">2</offsets></sub><offsets xml_i="14476" xml_f="14506" txt_i="8674" txt_f="8704">O every 30 seconds from 20 cmH</offsets><sub><offsets xml_i="14511" xml_f="14512" txt_i="8704" txt_f="8705">2</offsets></sub><offsets xml_i="14518" xml_f="14687" txt_i="8705" txt_f="8874">O while continuously monitoring saturation and static compliance. The decrease in PEEP was continued until a decrease of more than 2% of saturation from the previous SaO</offsets><sub><offsets xml_i="14692" xml_f="14694" txt_i="8874" txt_f="8876">2 </offsets></sub><offsets xml_i="14700" xml_f="14858" txt_i="8876" txt_f="9034">and drop of static compliance was identified. This PEEP level was considered the alveolar collapsing pressure and the optimal PEEP after the ARM was set 2 cmH</offsets><sub><offsets xml_i="14863" xml_f="14864" txt_i="9034" txt_f="9035">2</offsets></sub><offsets xml_i="14870" xml_f="14979" txt_i="9035" txt_f="9144">O above this pressure. No patients showed significant arrhythmia or gross barotraumas of any type during ARM.</offsets></p></sec><sec><title><offsets xml_i="15001" xml_f="15015" txt_i="9146" txt_f="9160">Rescue therapy</offsets></title><p><offsets xml_i="15026" xml_f="15250" txt_i="9161" txt_f="9385">If the level of inspired oxygen was not decreased to 0.6 or oxygenation improvement was not achieved after PEEP readjustment in all patients, rescue therapies such as prone position or nitric oxide inhalation were performed.</offsets></p></sec></sec><sec><title><offsets xml_i="15278" xml_f="15314" txt_i="9388" txt_f="9424">Outcome measures and data collection</offsets></title><p><offsets xml_i="15325" xml_f="15397" txt_i="9425" txt_f="9497">The primary end point was improvement in oxygenation (improvement of PaO</offsets><sub><offsets xml_i="15402" xml_f="15403" txt_i="9497" txt_f="9498">2</offsets></sub><offsets xml_i="15409" xml_f="15413" txt_i="9498" txt_f="9502">/FiO</offsets><sub><offsets xml_i="15418" xml_f="15420" txt_i="9502" txt_f="9504">2 </offsets></sub><offsets xml_i="15426" xml_f="15799" txt_i="9504" txt_f="9877">(PF) ratio). The secondary end points included respiratory mechanics (PEEP and dynamic compliance), ICU stay, duration of sedatives and paralysing agents and patient outcomes (28-day mortality, 60-day mortality, duration of mechanical ventilation). Responders were defined by a 20% improvement in the PF ratio on day 1 compared with day 0 (baseline) after PEEP adjustment [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="15831" xml_f="15833" txt_i="9877" txt_f="9879">14</offsets></xref><offsets xml_i="15840" xml_f="15842" txt_i="9879" txt_f="9881">].</offsets></p><sec><title><offsets xml_i="15858" xml_f="15879" txt_i="9882" txt_f="9903">Respiratory mechanics</offsets></title><p><offsets xml_i="15890" xml_f="15945" txt_i="9904" txt_f="9959">Airway pressure and flow were monitored continuously. V</offsets><sub><offsets xml_i="15950" xml_f="15951" txt_i="9959" txt_f="9960">T</offsets></sub><offsets xml_i="15957" xml_f="15988" txt_i="9960" txt_f="9991">, dynamic compliance (in ml/cmH</offsets><sub><offsets xml_i="15993" xml_f="15994" txt_i="9991" txt_f="9992">2</offsets></sub><offsets xml_i="16000" xml_f="16284" txt_i="9992" txt_f="10276">O), and peak airway, mean airway and minute ventilation were recorded at 30 minutes after the change of PEEP level in both groups. Because pressure control mode was the main ventilatory strategy, we monitored and compared the dynamic compliance and peak airway pressure in both group.</offsets></p></sec><sec><title><offsets xml_i="16306" xml_f="16336" txt_i="10278" txt_f="10308">Haemodynamics and gas exchange</offsets></title><p><offsets xml_i="16347" xml_f="16424" txt_i="10309" txt_f="10386">We collected arterial blood samples to measure partial pressure of oxygen (PO</offsets><sub><offsets xml_i="16429" xml_f="16430" txt_i="10386" txt_f="10387">2</offsets></sub><offsets xml_i="16436" xml_f="16478" txt_i="10387" txt_f="10429">), partial pressure of carbon dioxide (PCO</offsets><sub><offsets xml_i="16483" xml_f="16484" txt_i="10429" txt_f="10430">2</offsets></sub><offsets xml_i="16490" xml_f="16504" txt_i="10430" txt_f="10444">), pH, and SaO</offsets><sub><offsets xml_i="16509" xml_f="16511" txt_i="10444" txt_f="10446">2 </offsets></sub><offsets xml_i="16517" xml_f="16670" txt_i="10446" txt_f="10599">30 minutes after reapplication of PEEP. Haemodynamic variables monitored included heart rate and systolic, diastolic and mean systemic arterial pressure.</offsets></p></sec></sec><sec><title><offsets xml_i="16698" xml_f="16711" txt_i="10602" txt_f="10615">Data analysis</offsets></title><p><offsets xml_i="16722" xml_f="16922" txt_i="10616" txt_f="10816">Sample size calculation showed that 36 patients per group would provide 80% power at a two-sided α level of 0.05 to detect a 20% difference in the improvement of oxygenation (improvement of PF ratio).</offsets></p><p><offsets xml_i="16929" xml_f="17451" txt_i="10817" txt_f="11339">All data were analysed using SPSS for Windows (version 11.0; SPSS Inc., Chicago, IL, USA). Statistical analyses were based on the intention-to-treat principle and involved all patients who had undergone randomisation. All values are expressed as the mean ± standard error of the mean or as the number and percentage of patients. Probability of mortality and differences between the groups were compared using a log-rank test. The chi-squared test or Fisher's exact test was used to compare categorical data, and Student's </offsets><italic><offsets xml_i="17459" xml_f="17461" txt_i="11339" txt_f="11341">t </offsets></italic><offsets xml_i="17470" xml_f="17579" txt_i="11341" txt_f="11447">test or the Mann-Whitney U test was used to compare continuous data. Significance was defined as p &lt; 0.05.</offsets></p></sec></sec><sec><title><offsets xml_i="17607" xml_f="17614" txt_i="11450" txt_f="11457">Results</offsets></title><sec><title><offsets xml_i="17634" xml_f="17665" txt_i="11458" txt_f="11489">Characteristics of the patients</offsets></title><p><offsets xml_i="17676" xml_f="18071" txt_i="11490" txt_f="11885">We enrolled 61 patients in the study, 30 of whom were randomly assigned to the control (table-based PEEP setting) group and 31 to the decremental PEEP titration group. Fifty-seven patients completed the study (27 in the control group and 30 in the decremental PEEP titration group) and contributed data for the analyses. Most baseline characteristics were similar in the two study groups (Table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="18103" xml_f="18104" txt_i="11885" txt_f="11886">1</offsets></xref><offsets xml_i="18111" xml_f="18283" txt_i="11886" txt_f="12058">). The most common cause of ARDS was pneumonia. The initial ventilatory setting and severity index did not differ between the control and decremental PEEP titration groups.</offsets></p><table-wrap position="float" id="T1"><label><offsets xml_i="18331" xml_f="18338" txt_i="12059" txt_f="12066">Table 1</offsets></label><caption><p><offsets xml_i="18358" xml_f="18412" txt_i="12066" txt_f="12120">Baseline characteristics of the patients at enrollment</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center"><offsets xml_i="18502" xml_f="18515" txt_i="12122" txt_f="12135">Control group</offsets><break></break><offsets xml_i="18530" xml_f="18538" txt_i="12135" txt_f="12143">(n = 27)</offsets></td><td align="center"><offsets xml_i="18562" xml_f="18594" txt_i="12144" txt_f="12176">Decremental PEEP titration group</offsets><break></break><offsets xml_i="18609" xml_f="18617" txt_i="12176" txt_f="12184">(n = 30)</offsets></td></tr></thead><tbody><tr><td align="left"><offsets xml_i="18663" xml_f="18674" txt_i="12185" txt_f="12196">Age (years)</offsets></td><td align="center"><offsets xml_i="18698" xml_f="18708" txt_i="12197" txt_f="12207">62.0 ± 2.2</offsets></td><td align="center"><offsets xml_i="18732" xml_f="18742" txt_i="12208" txt_f="12218">55.0 ± 3.7</offsets></td></tr><tr><td align="left"><offsets xml_i="18773" xml_f="18792" txt_i="12219" txt_f="12238">Percentage of women</offsets></td><td align="center"><offsets xml_i="18816" xml_f="18818" txt_i="12239" txt_f="12241">37</offsets></td><td align="center"><offsets xml_i="18842" xml_f="18844" txt_i="12242" txt_f="12244">40</offsets></td></tr><tr><td align="left"><offsets xml_i="18875" xml_f="18890" txt_i="12245" txt_f="12260">APACHE II score</offsets></td><td align="center"><offsets xml_i="18914" xml_f="18924" txt_i="12261" txt_f="12271">20.0 ± 1.4</offsets></td><td align="center"><offsets xml_i="18948" xml_f="18958" txt_i="12272" txt_f="12282">22.0 ± 1.1</offsets></td></tr><tr><td align="left"><offsets xml_i="18989" xml_f="19006" txt_i="12283" txt_f="12300">Lung injury score</offsets></td><td align="center"><offsets xml_i="19030" xml_f="19039" txt_i="12301" txt_f="12310">2.5 ± 0.1</offsets></td><td align="center"><offsets xml_i="19063" xml_f="19072" txt_i="12311" txt_f="12320">2.8 ± 0.2</offsets></td></tr><tr><td align="left"><offsets xml_i="19103" xml_f="19148" txt_i="12321" txt_f="12366">Tidal volume (ml/kg of predicted body weight)</offsets></td><td align="center"><offsets xml_i="19172" xml_f="19181" txt_i="12367" txt_f="12376">8.0 ± 1.4</offsets></td><td align="center"><offsets xml_i="19205" xml_f="19214" txt_i="12377" txt_f="12386">7.9 ± 1.9</offsets></td></tr><tr><td align="left"><offsets xml_i="19245" xml_f="19278" txt_i="12387" txt_f="12420">Respiratory rate (breaths/minute)</offsets></td><td align="center"><offsets xml_i="19302" xml_f="19312" txt_i="12421" txt_f="12431">22.0 ± 3.0</offsets></td><td align="center"><offsets xml_i="19336" xml_f="19346" txt_i="12432" txt_f="12442">22.2 ± 3.2</offsets></td></tr><tr><td align="left"><offsets xml_i="19377" xml_f="19402" txt_i="12443" txt_f="12468">Peak airway pressure (cmH</offsets><sub><offsets xml_i="19407" xml_f="19408" txt_i="12468" txt_f="12469">2</offsets></sub><offsets xml_i="19414" xml_f="19416" txt_i="12469" txt_f="12471">O)</offsets></td><td align="center"><offsets xml_i="19440" xml_f="19450" txt_i="12472" txt_f="12482">25.9 ± 5.9</offsets></td><td align="center"><offsets xml_i="19474" xml_f="19484" txt_i="12483" txt_f="12493">27.8 ± 5.5</offsets></td></tr><tr><td align="left"><offsets xml_i="19515" xml_f="19552" txt_i="12494" txt_f="12531">Positive end-expiratory pressure (cmH</offsets><sub><offsets xml_i="19557" xml_f="19558" txt_i="12531" txt_f="12532">2</offsets></sub><offsets xml_i="19564" xml_f="19566" txt_i="12532" txt_f="12534">O)</offsets></td><td align="center"><offsets xml_i="19590" xml_f="19599" txt_i="12535" txt_f="12544">7.0 ± 3.7</offsets></td><td align="center"><offsets xml_i="19623" xml_f="19632" txt_i="12545" txt_f="12554">8.4 ± 3.1</offsets></td></tr><tr><td align="left"><offsets xml_i="19663" xml_f="19695" txt_i="12555" txt_f="12587">Dynamic compliance (Cdyn, ml/cmH</offsets><sub><offsets xml_i="19700" xml_f="19701" txt_i="12587" txt_f="12588">2</offsets></sub><offsets xml_i="19707" xml_f="19709" txt_i="12588" txt_f="12590">O)</offsets></td><td align="center"><offsets xml_i="19733" xml_f="19743" txt_i="12591" txt_f="12601">25.7 ± 8.1</offsets></td><td align="center"><offsets xml_i="19767" xml_f="19777" txt_i="12602" txt_f="12612">24.3 ± 7.6</offsets></td></tr><tr><td align="left"><offsets xml_i="19808" xml_f="19821" txt_i="12613" txt_f="12626">PF ratio (PaO</offsets><sub><offsets xml_i="19826" xml_f="19827" txt_i="12626" txt_f="12627">2</offsets></sub><offsets xml_i="19833" xml_f="19837" txt_i="12627" txt_f="12631">:FiO</offsets><sub><offsets xml_i="19842" xml_f="19843" txt_i="12631" txt_f="12632">2</offsets></sub><offsets xml_i="19849" xml_f="19850" txt_i="12632" txt_f="12633">)</offsets></td><td align="center"><offsets xml_i="19874" xml_f="19885" txt_i="12634" txt_f="12645">110.8 ± 6.3</offsets></td><td align="center"><offsets xml_i="19909" xml_f="19920" txt_i="12646" txt_f="12657">115.0 ± 8.5</offsets></td></tr><tr><td align="left"><offsets xml_i="19951" xml_f="19968" txt_i="12658" txt_f="12675">Co-morbidities, n</offsets></td><td></td><td></td></tr><tr><td align="left"><offsets xml_i="20017" xml_f="20043" txt_i="12678" txt_f="12704"> Haematological malignancy</offsets></td><td align="center"><offsets xml_i="20067" xml_f="20068" txt_i="12705" txt_f="12706">3</offsets></td><td align="center"><offsets xml_i="20092" xml_f="20093" txt_i="12707" txt_f="12708">7</offsets></td></tr><tr><td align="left"><offsets xml_i="20124" xml_f="20147" txt_i="12709" txt_f="12732"> Solid organ malignancy</offsets></td><td align="center"><offsets xml_i="20171" xml_f="20172" txt_i="12733" txt_f="12734">6</offsets></td><td align="center"><offsets xml_i="20196" xml_f="20197" txt_i="12735" txt_f="12736">4</offsets></td></tr><tr><td align="left"><offsets xml_i="20228" xml_f="20250" txt_i="12737" txt_f="12759"> Chronic liver disease</offsets></td><td align="center"><offsets xml_i="20274" xml_f="20275" txt_i="12760" txt_f="12761">5</offsets></td><td align="center"><offsets xml_i="20299" xml_f="20300" txt_i="12762" txt_f="12763">3</offsets></td></tr><tr><td align="left"><offsets xml_i="20331" xml_f="20357" txt_i="12764" txt_f="12790"> Connective tissue disease</offsets></td><td align="center"><offsets xml_i="20381" xml_f="20382" txt_i="12791" txt_f="12792">2</offsets></td><td align="center"><offsets xml_i="20406" xml_f="20407" txt_i="12793" txt_f="12794">1</offsets></td></tr><tr><td align="left"><offsets xml_i="20438" xml_f="20445" txt_i="12795" txt_f="12802"> Others</offsets><sup><offsets xml_i="20450" xml_f="20451" txt_i="12802" txt_f="12803">a</offsets></sup></td><td align="center"><offsets xml_i="20481" xml_f="20482" txt_i="12804" txt_f="12805">3</offsets></td><td align="center"><offsets xml_i="20506" xml_f="20507" txt_i="12806" txt_f="12807">3</offsets></td></tr><tr><td align="left"><offsets xml_i="20538" xml_f="20574" txt_i="12808" txt_f="12844">Cause of lung injury (ARDSp:ARDSexp)</offsets></td><td align="center"><offsets xml_i="20598" xml_f="20602" txt_i="12845" txt_f="12849">18:9</offsets></td><td align="center"><offsets xml_i="20626" xml_f="20631" txt_i="12850" txt_f="12855">20:10</offsets></td></tr><tr><td align="left"><offsets xml_i="20662" xml_f="20672" txt_i="12856" txt_f="12866"> Pneumonia</offsets></td><td align="center"><offsets xml_i="20696" xml_f="20698" txt_i="12867" txt_f="12869">15</offsets></td><td align="center"><offsets xml_i="20722" xml_f="20724" txt_i="12870" txt_f="12872">17</offsets></td></tr><tr><td align="left"><offsets xml_i="20755" xml_f="20762" txt_i="12873" txt_f="12880"> Sepsis</offsets></td><td align="center"><offsets xml_i="20786" xml_f="20787" txt_i="12881" txt_f="12882">7</offsets></td><td align="center"><offsets xml_i="20811" xml_f="20812" txt_i="12883" txt_f="12884">7</offsets></td></tr><tr><td align="left"><offsets xml_i="20843" xml_f="20863" txt_i="12885" txt_f="12905"> Massive transfusion</offsets></td><td align="center"><offsets xml_i="20887" xml_f="20888" txt_i="12906" txt_f="12907">2</offsets></td><td align="center"><offsets xml_i="20912" xml_f="20913" txt_i="12908" txt_f="12909">1</offsets></td></tr><tr><td align="left"><offsets xml_i="20944" xml_f="20975" txt_i="12910" txt_f="12941"> Pulmonary alveolar haemorrhage</offsets></td><td align="center"><offsets xml_i="20999" xml_f="21000" txt_i="12942" txt_f="12943">1</offsets></td><td align="center"><offsets xml_i="21024" xml_f="21025" txt_i="12944" txt_f="12945">1</offsets></td></tr><tr><td align="left"><offsets xml_i="21056" xml_f="21063" txt_i="12946" txt_f="12953"> Others</offsets><sup><offsets xml_i="21068" xml_f="21069" txt_i="12953" txt_f="12954">b</offsets></sup></td><td align="center"><offsets xml_i="21099" xml_f="21100" txt_i="12955" txt_f="12956">2</offsets></td><td align="center"><offsets xml_i="21124" xml_f="21125" txt_i="12957" txt_f="12958">4</offsets></td></tr></tbody></table><table-wrap-foot><p><offsets xml_i="21171" xml_f="21228" txt_i="12959" txt_f="13016">Data was presented as mean ± standard error of the mean. </offsets><sup><offsets xml_i="21233" xml_f="21235" txt_i="13016" txt_f="13018">a </offsets></sup><offsets xml_i="21241" xml_f="21332" txt_i="13018" txt_f="13109">including complicated diabetes mellitus (n = 4), Crohn's disease (n = 1) and AIDS (n = 1). </offsets><sup><offsets xml_i="21337" xml_f="21339" txt_i="13109" txt_f="13111">b </offsets></sup><offsets xml_i="21345" xml_f="21560" txt_i="13111" txt_f="13326">including leptospirosis (n = 3), near-drowning (n = 1), contusion (n = 1) and scrub typhus (n = 1). APACHE = acute physiology and chronic health evaluation; ARDSp = pulmonary ARDS; ARDSexp = extrapulmonary ARDS; FiO</offsets><sub><offsets xml_i="21565" xml_f="21567" txt_i="13326" txt_f="13328">2 </offsets></sub><offsets xml_i="21573" xml_f="21607" txt_i="13328" txt_f="13362">= inspired fracture of oxygen; PaO</offsets><sub><offsets xml_i="21612" xml_f="21614" txt_i="13362" txt_f="13364">2 </offsets></sub><offsets xml_i="21620" xml_f="21699" txt_i="13364" txt_f="13443">= partial arterial pressure of oxygen; PEEP = positive end-expiratory pressure.</offsets></p></table-wrap-foot></table-wrap></sec><sec><title><offsets xml_i="21752" xml_f="21789" txt_i="13445" txt_f="13482">Respiratory mechanics and oxygenation</offsets></title><p><offsets xml_i="21800" xml_f="21807" txt_i="13483" txt_f="13490">Figure </offsets><xref ref-type="fig" rid="F3"><offsets xml_i="21837" xml_f="21838" txt_i="13490" txt_f="13491">3</offsets></xref><offsets xml_i="21845" xml_f="22251" txt_i="13491" txt_f="13897"> shows the ventilatory setting and respiratory variables at baseline and follow-up during the first week of treatment. The peak pressure was significantly higher on days 3 and 5 in the decremental PEEP titration group than in the control group, and the mean pressure was significantly higher in the decremental PEEP titration group because of the higher PEEP during the first week. Dynamic compliance and V</offsets><sub><offsets xml_i="22256" xml_f="22258" txt_i="13897" txt_f="13899">T </offsets></sub><offsets xml_i="22264" xml_f="22398" txt_i="13899" txt_f="14033">during the first week were similar in the two groups. Oxygenation improved compared with the baseline PF ratio in both groups (Figure </offsets><xref ref-type="fig" rid="F4"><offsets xml_i="22428" xml_f="22429" txt_i="14033" txt_f="14034">4</offsets></xref><offsets xml_i="22436" xml_f="22585" txt_i="14034" txt_f="14183">). Initial oxygenation improved more in the decremental PEEP titration group than in the control group. The partial arterial pressure of oxygen (PaCO</offsets><sub><offsets xml_i="22590" xml_f="22591" txt_i="14183" txt_f="14184">2</offsets></sub><offsets xml_i="22597" xml_f="22799" txt_i="14184" txt_f="14386">) level was significantly higher in the decremental PEEP titration group than in the control group on day 1, suggesting increased dead space ventilation. However, the improvement of oxygenation and PaCO</offsets><sub><offsets xml_i="22804" xml_f="22806" txt_i="14386" txt_f="14388">2 </offsets></sub><offsets xml_i="22812" xml_f="22877" txt_i="14388" txt_f="14453">level were not different between the two groups during follow-up.</offsets></p><fig position="float" id="F3"><label><offsets xml_i="22918" xml_f="22926" txt_i="14454" txt_f="14462">Figure 3</offsets></label><caption><p><offsets xml_i="22946" xml_f="23290" txt_i="14462" txt_f="14803">Respiratory values during the first week of treatment. The closed circles indicate the control group and the open circles denote the decremental positive end-expiratory pressure (PEEP) titration group. Values are expressed as the mean ± standard error of the mean (bars). *p &lt; 0.05 between the control and decremental PEEP titration groups; </offsets><sup><offsets xml_i="23295" xml_f="23296" txt_i="14803" txt_f="14804">†</offsets></sup><offsets xml_i="23302" xml_f="23356" txt_i="14804" txt_f="14855">p &lt; 0.05 compared with day 0 in the control group; </offsets><sup><offsets xml_i="23361" xml_f="23362" txt_i="14855" txt_f="14856">‡</offsets></sup><offsets xml_i="23368" xml_f="23440" txt_i="14856" txt_f="14925">p &lt; 0.05 compared with day 0 in the decremental PEEP titration group.</offsets></p></caption><graphic xlink:href="cc7725-3"></graphic></fig><fig position="float" id="F4"><label><offsets xml_i="23538" xml_f="23546" txt_i="14926" txt_f="14934">Figure 4</offsets></label><caption><p><offsets xml_i="23566" xml_f="23594" txt_i="14934" txt_f="14962">Oxygenation changes and PaCO</offsets><sub><offsets xml_i="23599" xml_f="23601" txt_i="14962" txt_f="14964">2 </offsets></sub><offsets xml_i="23607" xml_f="23771" txt_i="14964" txt_f="15128">levels during the first week of treatment. All patients showed improved oxygenation during treatment. The level of partial arterial pressure of carbon dioxide (PaCO</offsets><sub><offsets xml_i="23776" xml_f="23777" txt_i="15128" txt_f="15129">2</offsets></sub><offsets xml_i="23783" xml_f="24164" txt_i="15129" txt_f="15507">) at day 1 was increased significantly in the decremental positive end-expiratory pressure (PEEP) titration group than the control group. The black bars indicate the control group and gray bars denote the decremental PEEP titration group. Values are expressed as the mean ± standard error of the mean (bars). *p &lt; 0.05 between the control and decremental PEEP titration groups, </offsets><sup><offsets xml_i="24169" xml_f="24170" txt_i="15507" txt_f="15508">†</offsets></sup><offsets xml_i="24176" xml_f="24230" txt_i="15508" txt_f="15559">p &lt; 0.05 compared with day 0 in the control group, </offsets><sup><offsets xml_i="24235" xml_f="24236" txt_i="15559" txt_f="15560">‡</offsets></sup><offsets xml_i="24242" xml_f="24314" txt_i="15560" txt_f="15629">p &lt; 0.05 compared with day 0 in the decremental PEEP titration group.</offsets></p></caption><graphic xlink:href="cc7725-4"></graphic></fig></sec><sec><title><offsets xml_i="24393" xml_f="24410" txt_i="15631" txt_f="15648">Clinical outcomes</offsets></title><p><offsets xml_i="24421" xml_f="24568" txt_i="15649" txt_f="15796">The overall mortality at 28 days was 37%. Mortality at 28 days was 33% in the control group and 40% in the decremental PEEP titration group (Table </offsets><xref ref-type="table" rid="T2"><offsets xml_i="24600" xml_f="24601" txt_i="15796" txt_f="15797">2</offsets></xref><offsets xml_i="24608" xml_f="24947" txt_i="15797" txt_f="16136">). Using Cox regression for 28-day mortality, the survival rate in the decremental PEEP titration group was not different (p = 0.725; hazard ratio = 1.168; 95% confidence interval = 0.493 to 2.768). However, 60-day mortality was significantly increased to 55.6% (p = 0.031) compared with 28-day mortality (33.3%) in the control group only.</offsets></p><table-wrap position="float" id="T2"><label><offsets xml_i="24995" xml_f="25002" txt_i="16137" txt_f="16144">Table 2</offsets></label><caption><p><offsets xml_i="25022" xml_f="25068" txt_i="16144" txt_f="16190">Clinical outcomes according to treatment group</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center"><offsets xml_i="25158" xml_f="25171" txt_i="16192" txt_f="16205">Control group</offsets><break></break><offsets xml_i="25186" xml_f="25194" txt_i="16205" txt_f="16213">(n = 27)</offsets></td><td align="center"><offsets xml_i="25218" xml_f="25250" txt_i="16214" txt_f="16246">Decremental PEEP titration group</offsets><break></break><offsets xml_i="25265" xml_f="25273" txt_i="16246" txt_f="16254">(n = 30)</offsets></td><td align="center"><offsets xml_i="25297" xml_f="25304" txt_i="16255" txt_f="16262">p value</offsets></td></tr></thead><tbody><tr><td align="left"><offsets xml_i="25350" xml_f="25363" txt_i="16263" txt_f="16276">Responder (%)</offsets></td><td align="center"><offsets xml_i="25387" xml_f="25391" txt_i="16277" txt_f="16281">44.4</offsets></td><td align="center"><offsets xml_i="25415" xml_f="25417" txt_i="16282" txt_f="16284">70</offsets></td><td align="center"><offsets xml_i="25441" xml_f="25446" txt_i="16285" txt_f="16290">0.046</offsets></td></tr><tr><td align="left"><offsets xml_i="25477" xml_f="25494" txt_i="16291" txt_f="16308">Clinical outcomes</offsets></td><td></td><td></td><td></td></tr><tr><td align="left"><offsets xml_i="25552" xml_f="25593" txt_i="16312" txt_f="16353"> Duration of mechanical ventilation, days</offsets></td><td align="center"><offsets xml_i="25617" xml_f="25627" txt_i="16354" txt_f="16364">15.2 ± 3.2</offsets></td><td align="center"><offsets xml_i="25651" xml_f="25661" txt_i="16365" txt_f="16375">19.8 ± 0.5</offsets></td><td align="center"><offsets xml_i="25685" xml_f="25690" txt_i="16376" txt_f="16381">0.380</offsets></td></tr><tr><td align="left"><offsets xml_i="25721" xml_f="25752" txt_i="16382" txt_f="16413"> Intensive care unit stay, days</offsets></td><td align="center"><offsets xml_i="25776" xml_f="25786" txt_i="16414" txt_f="16424">21.4 ± 5.3</offsets></td><td align="center"><offsets xml_i="25810" xml_f="25820" txt_i="16425" txt_f="16435">25.1 ± 5.6</offsets></td><td align="center"><offsets xml_i="25844" xml_f="25849" txt_i="16436" txt_f="16441">0.643</offsets></td></tr><tr><td align="left"><offsets xml_i="25880" xml_f="25915" txt_i="16442" txt_f="16477"> Duration of paralysing agent, days</offsets></td><td align="center"><offsets xml_i="25939" xml_f="25948" txt_i="16478" txt_f="16487">9.0 ± 2.3</offsets></td><td align="center"><offsets xml_i="25972" xml_f="25982" txt_i="16488" txt_f="16498">11.8 ± 2.0</offsets></td><td align="center"><offsets xml_i="26006" xml_f="26011" txt_i="16499" txt_f="16504">0.358</offsets></td></tr><tr><td align="left"><offsets xml_i="26042" xml_f="26076" txt_i="16505" txt_f="16539"> Duration of sedative agents, days</offsets></td><td align="center"><offsets xml_i="26100" xml_f="26110" txt_i="16540" txt_f="16550">14.2 ± 2.4</offsets></td><td align="center"><offsets xml_i="26134" xml_f="26144" txt_i="16551" txt_f="16561">18.7 ± 3.4</offsets></td><td align="center"><offsets xml_i="26168" xml_f="26173" txt_i="16562" txt_f="16567">0.303</offsets></td></tr><tr><td align="left"><offsets xml_i="26204" xml_f="26236" txt_i="16568" txt_f="16600"> Weaning trial within seven days</offsets></td><td align="center"><offsets xml_i="26260" xml_f="26261" txt_i="16601" txt_f="16602">8</offsets></td><td align="center"><offsets xml_i="26285" xml_f="26286" txt_i="16603" txt_f="16604">6</offsets></td><td></td></tr><tr><td align="left"><offsets xml_i="26326" xml_f="26339" txt_i="16606" txt_f="16619"> Tracheostomy</offsets></td><td align="center"><offsets xml_i="26363" xml_f="26364" txt_i="16620" txt_f="16621">5</offsets></td><td align="center"><offsets xml_i="26388" xml_f="26389" txt_i="16622" txt_f="16623">8</offsets></td><td></td></tr><tr><td align="left"><offsets xml_i="26429" xml_f="26442" txt_i="16625" txt_f="16638"> Reintubation</offsets></td><td align="center"><offsets xml_i="26466" xml_f="26467" txt_i="16639" txt_f="16640">5</offsets></td><td align="center"><offsets xml_i="26491" xml_f="26492" txt_i="16641" txt_f="16642">2</offsets></td><td></td></tr><tr><td align="left"><offsets xml_i="26532" xml_f="26543" txt_i="16644" txt_f="16655"> Barotrauma</offsets></td><td align="center"><offsets xml_i="26567" xml_f="26568" txt_i="16656" txt_f="16657">3</offsets></td><td align="center"><offsets xml_i="26592" xml_f="26593" txt_i="16658" txt_f="16659">3</offsets></td><td></td></tr><tr><td align="left"><offsets xml_i="26633" xml_f="26665" txt_i="16661" txt_f="16693"> Ventilator-associated pneumonia</offsets></td><td align="center"><offsets xml_i="26689" xml_f="26690" txt_i="16694" txt_f="16695">5</offsets></td><td align="center"><offsets xml_i="26714" xml_f="26715" txt_i="16696" txt_f="16697">5</offsets></td><td></td></tr><tr><td align="left"><offsets xml_i="26755" xml_f="26776" txt_i="16699" txt_f="16720">Mortality, number (%)</offsets></td><td></td><td></td><td></td></tr><tr><td align="left"><offsets xml_i="26834" xml_f="26855" txt_i="16724" txt_f="16745"> Mortality at 28 days</offsets></td><td align="center"><offsets xml_i="26879" xml_f="26887" txt_i="16746" txt_f="16754">9 (33.3)</offsets></td><td align="center"><offsets xml_i="26911" xml_f="26918" txt_i="16755" txt_f="16762">12 (40)</offsets></td><td align="center"><offsets xml_i="26942" xml_f="26947" txt_i="16763" txt_f="16768">0.784</offsets></td></tr><tr><td align="left"><offsets xml_i="26978" xml_f="27011" txt_i="16769" txt_f="16802"> Death in the intensive care unit</offsets></td><td align="center"><offsets xml_i="27035" xml_f="27044" txt_i="16803" txt_f="16812">13 (48.1)</offsets></td><td align="center"><offsets xml_i="27068" xml_f="27077" txt_i="16813" txt_f="16822">14 (46.7)</offsets></td><td align="center"><offsets xml_i="27101" xml_f="27106" txt_i="16823" txt_f="16828">1.000</offsets></td></tr><tr><td align="left"><offsets xml_i="27137" xml_f="27158" txt_i="16829" txt_f="16850"> Mortality at 60 days</offsets></td><td align="center"><offsets xml_i="27182" xml_f="27191" txt_i="16851" txt_f="16860">15 (55.6)</offsets></td><td align="center"><offsets xml_i="27215" xml_f="27224" txt_i="16861" txt_f="16870">14 (46.7)</offsets></td><td align="center"><offsets xml_i="27248" xml_f="27253" txt_i="16871" txt_f="16876">0.599</offsets></td></tr><tr><td align="left"><offsets xml_i="27284" xml_f="27322" txt_i="16877" txt_f="16915">Cause of in-hospital death, number (%)</offsets></td><td></td><td></td><td></td></tr><tr><td align="left"><offsets xml_i="27380" xml_f="27412" txt_i="16919" txt_f="16951"> Progressive respiratory failure</offsets></td><td align="center"><offsets xml_i="27436" xml_f="27444" txt_i="16952" txt_f="16960">8 (53.3)</offsets></td><td align="center"><offsets xml_i="27468" xml_f="27476" txt_i="16961" txt_f="16969">8 (57.1)</offsets></td><td></td></tr><tr><td align="left"><offsets xml_i="27516" xml_f="27540" txt_i="16971" txt_f="16995"> Refractory septic shock</offsets></td><td align="center"><offsets xml_i="27564" xml_f="27572" txt_i="16996" txt_f="17004">4 (26.7)</offsets></td><td align="center"><offsets xml_i="27596" xml_f="27604" txt_i="17005" txt_f="17013">2 (14.3)</offsets></td><td></td></tr><tr><td align="left"><offsets xml_i="27644" xml_f="27660" txt_i="17015" txt_f="17031"> Hepatic failure</offsets></td><td align="center"><offsets xml_i="27684" xml_f="27690" txt_i="17032" txt_f="17038">3 (20)</offsets></td><td align="center"><offsets xml_i="27714" xml_f="27722" txt_i="17039" txt_f="17047">2 (14.3)</offsets></td><td></td></tr><tr><td align="left"><offsets xml_i="27762" xml_f="27784" txt_i="17049" txt_f="17071"> Myocardial infarction</offsets></td><td></td><td align="center"><offsets xml_i="27817" xml_f="27825" txt_i="17073" txt_f="17081">2 (14.3)</offsets></td><td></td></tr><tr><td align="left"><offsets xml_i="27865" xml_f="27883" txt_i="17083" txt_f="17101">Rescue therapy (%)</offsets></td><td></td><td></td><td></td></tr><tr><td align="left"><offsets xml_i="27941" xml_f="27956" txt_i="17105" txt_f="17120"> Prone position</offsets></td><td align="center"><offsets xml_i="27980" xml_f="27984" txt_i="17121" txt_f="17125">44.4</offsets></td><td align="center"><offsets xml_i="28008" xml_f="28012" txt_i="17126" txt_f="17130">50.0</offsets></td><td align="center"><offsets xml_i="28036" xml_f="28041" txt_i="17131" txt_f="17136">0.792</offsets></td></tr><tr><td align="left"><offsets xml_i="28072" xml_f="28096" txt_i="17137" txt_f="17161"> Nitric oxide inhalation</offsets></td><td align="center"><offsets xml_i="28120" xml_f="28124" txt_i="17162" txt_f="17166">48.1</offsets></td><td align="center"><offsets xml_i="28148" xml_f="28152" txt_i="17167" txt_f="17171">53.3</offsets></td><td align="center"><offsets xml_i="28176" xml_f="28181" txt_i="17172" txt_f="17177">0.793</offsets></td></tr></tbody></table><table-wrap-foot><p><offsets xml_i="28227" xml_f="28324" txt_i="17178" txt_f="17275">Data was presented as mean ± standard error of the mean. PEEP = positive end-expiratory pressure.</offsets></p></table-wrap-foot></table-wrap><p><offsets xml_i="28362" xml_f="28716" txt_i="17276" txt_f="17630">Eight patients (30%) in the control group and six patients (20%) in the decremental PEEP titration group had performed the weaning trial within a week of enrollment. The incidence of barotrauma was similar in both groups. The durations of mechanical ventilation, ICU stay and use of paralysing or sedative agents did not differ between the groups (Table </offsets><xref ref-type="table" rid="T2"><offsets xml_i="28748" xml_f="28749" txt_i="17630" txt_f="17631">2</offsets></xref><offsets xml_i="28756" xml_f="28758" txt_i="17631" txt_f="17633">).</offsets></p></sec></sec><sec><title><offsets xml_i="28786" xml_f="28796" txt_i="17636" txt_f="17646">Discussion</offsets></title><p><offsets xml_i="28807" xml_f="28856" txt_i="17647" txt_f="17696">As suggested by Lachmann more than 10 years ago [</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="28888" xml_f="28890" txt_i="17696" txt_f="17698">15</offsets></xref><offsets xml_i="28897" xml_f="29052" txt_i="17698" txt_f="17853">], "open up the lung and keep the lung open" appears advantageous to recruit the lungs of patients with ARDS and to prevent subsequent lung derecruitment [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="29084" xml_f="29086" txt_i="17853" txt_f="17855">12</offsets></xref><offsets xml_i="29093" xml_f="29209" txt_i="17855" txt_f="17971">]. Clinical outcomes were similar regardless of whether lower or higher PEEP levels were used in the ALVEOLI trial [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="29240" xml_f="29241" txt_i="17971" txt_f="17972">7</offsets></xref><offsets xml_i="29248" xml_f="29756" txt_i="17972" txt_f="18480">]. The problem of the ALVEOLI trial was the higher PEEP strategy, which was table-based like the one on the current study, matched on the oxygenation target regardless of any patient-related variable. A reasonable approach to determining the appropriate level of PEEP requires maintaining PEEP-induced reopening of atelectatic areas and avoiding PEEP-induced lung overinflation. Higher than traditional PEEP levels together with lung-recruiting maneuvers seems to be a way to find an appropriate PEEP level [</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="29788" xml_f="29790" txt_i="18480" txt_f="18482">16</offsets></xref><offsets xml_i="29797" xml_f="29799" txt_i="18482" txt_f="18484">].</offsets></p><p><offsets xml_i="29806" xml_f="29959" txt_i="18485" txt_f="18638">Experimental data suggest that the effects of ARM on alveolar recruitment are transient if the preceding PEEP levels are maintained after the manoeuvre [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="29991" xml_f="29993" txt_i="18638" txt_f="18640">14</offsets></xref><offsets xml_i="30000" xml_f="30095" txt_i="18640" txt_f="18735">]. Once the alveoli have been recruited, higher PEEP levels are required to keep them aerated [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="30127" xml_f="30129" txt_i="18735" txt_f="18737">17</offsets></xref><offsets xml_i="30136" xml_f="30354" txt_i="18737" txt_f="18955">]. The right level of PEEP as an anti-derecruiting force is important in preserving the effect of the ARM. We previously reported that a sufficient level of PEEP after ARM is important as an anti-decruitment strategy [</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="30386" xml_f="30388" txt_i="18955" txt_f="18957">18</offsets></xref><offsets xml_i="30395" xml_f="30397" txt_i="18957" txt_f="18959">].</offsets></p><p></p><p><offsets xml_i="30411" xml_f="30781" txt_i="18961" txt_f="19331">Our finding showed the 60-day mortality in the control group was significantly increased compared with the 28-day mortality. We could not explain whether this finding was associated with the protective effect of ARM to the ventilator-induced lung injury. To add any relevant information, further study will be needed for the biomarkers such as proinflammatory cytokines.</offsets></p><p><offsets xml_i="30788" xml_f="31271" txt_i="19332" txt_f="19815">The lower dynamic compliance in the decremental PEEP titration group was an unexpected result, although there was no significant difference between the two groups. We speculated that a higher peak airway pressure might affect the lower dynamic compliance in the decremental PEEP titration group than the control. A reason for this result might be related to the subjects' characteristics. Most of the patients with ARDS had pneumonia, which did not respond well to the applied PEEP [</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="31303" xml_f="31305" txt_i="19815" txt_f="19817">19</offsets></xref><offsets xml_i="31312" xml_f="31314" txt_i="19817" txt_f="19819">].</offsets></p><p><offsets xml_i="31321" xml_f="31894" txt_i="19820" txt_f="20393">We included mostly pulmonary ARDS with severe underlying diseases, which would be a common phenomenon in a university hospital MICU. That may be the reason why mortality related to progressive respiratory failure was higher in our study group. The mortality of patients with pneumonia was 43.3% and the mortality of patients without pneumonia was 29.6%. The baseline lung conditions of these patients was a higher proportion of refractory consolidation to the distending pressure which may also have influenced the PF ratio of less than 250 and PEEP levels less than 15 cmH</offsets><sub><offsets xml_i="31899" xml_f="31900" txt_i="20393" txt_f="20394">2</offsets></sub><offsets xml_i="31906" xml_f="32039" txt_i="20394" txt_f="20527">O after ARM. Talmor and colleagues reported that a low lung distending pressure was applied in the patients with a stiff chest wall [</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="32071" xml_f="32073" txt_i="20527" txt_f="20529">20</offsets></xref><offsets xml_i="32080" xml_f="32220" txt_i="20529" txt_f="20669">]. We did not measure the chest-wall mechanics or the recruitable lung, so we could not address this possibility as a cause of low PF ratio.</offsets></p><p><offsets xml_i="32227" xml_f="32545" txt_i="20670" txt_f="20988">One limitation of our study is that we could not evaluate whether recruitment manoeuvre maximised the alveolar collapse. If the recruitment effect of our ARM was not sufficient, the effect of a decremental PEEP trial might be insufficient. Borges and colleagues reported that a peak airway pressure of more than 60 cmH</offsets><sub><offsets xml_i="32550" xml_f="32551" txt_i="20988" txt_f="20989">2</offsets></sub><offsets xml_i="32557" xml_f="32593" txt_i="20989" txt_f="21025">O could recruit the collapsed lung [</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="32625" xml_f="32627" txt_i="21025" txt_f="21027">21</offsets></xref><offsets xml_i="32634" xml_f="32909" txt_i="21027" txt_f="21302">]. Another limitation is that our indicators of oxygen saturation and static compliance to find an appropriate PEEP level might be insensitive to detect the collapsing pressure of the lung. Finally, small sample size in a single centre limits the power of the study outcomes.</offsets></p></sec><sec><title><offsets xml_i="32931" xml_f="32941" txt_i="21304" txt_f="21314">Conclusion</offsets></title><p><offsets xml_i="32952" xml_f="33308" txt_i="21315" txt_f="21671">The daily decremental PEEP titration after ARM did not show the persistent improvement of oxygenation, the respiratory mechanics and the mortality rate of patients with ARDS compared with the table-based PEEP setting. Further investigations are needed to find the correct level of PEEP in ARDS with reference to chest wall compliance and alveoli mechanics.</offsets></p></sec><sec><title><offsets xml_i="33330" xml_f="33342" txt_i="21673" txt_f="21685">Key messages</offsets></title><p><offsets xml_i="33353" xml_f="33462" txt_i="21686" txt_f="21795">• The daily decremental PEEP titration after ARM method did not show a persistent improvement of oxygenation.</offsets></p><p><offsets xml_i="33469" xml_f="33522" txt_i="21796" txt_f="21849">• Respiratory mechanics such as dynamic compliance, V</offsets><sub><offsets xml_i="33527" xml_f="33529" txt_i="21849" txt_f="21851">T </offsets></sub><offsets xml_i="33535" xml_f="33677" txt_i="21851" txt_f="21993">and PEEP were not significantly different between the daily decremental PEEP titration after ARM group and the table-based PEEP setting group.</offsets></p><p><offsets xml_i="33684" xml_f="33900" txt_i="21994" txt_f="22210">• The daily decremental PEEP titration after ARM without the reference of lung mechanics did not reduce the dependence of ventilator or mortality rate of patients with ARDS compared with the table-based PEEP setting.</offsets></p></sec><sec><title><offsets xml_i="33922" xml_f="33935" txt_i="22212" txt_f="22225">Abbreviations</offsets></title><p><offsets xml_i="33946" xml_f="34053" txt_i="22226" txt_f="22333">ALI: acute lung injury; ARDS: acute respiratory distress syndrome; ARM: alveolar recruitment manoeuvre; FiO</offsets><sub><offsets xml_i="34058" xml_f="34059" txt_i="22333" txt_f="22334">2</offsets></sub><offsets xml_i="34065" xml_f="34175" txt_i="22334" txt_f="22444">: inspired fracture of oxygen; MICU: medical intensive care unit; PEEP: positive end-expiratory pressure; PaCO</offsets><sub><offsets xml_i="34180" xml_f="34181" txt_i="22444" txt_f="22445">2</offsets></sub><offsets xml_i="34187" xml_f="34237" txt_i="22445" txt_f="22495">: partial arterial pressure of carbon dioxide; PaO</offsets><sub><offsets xml_i="34242" xml_f="34243" txt_i="22495" txt_f="22496">2</offsets></sub><offsets xml_i="34249" xml_f="34291" txt_i="22496" txt_f="22538">: partial arterial pressure of oxygen; PCO</offsets><sub><offsets xml_i="34296" xml_f="34297" txt_i="22538" txt_f="22539">2</offsets></sub><offsets xml_i="34303" xml_f="34343" txt_i="22539" txt_f="22579">: partial pressure of carbon dioxide; PO</offsets><sub><offsets xml_i="34348" xml_f="34349" txt_i="22579" txt_f="22580">2</offsets></sub><offsets xml_i="34355" xml_f="34388" txt_i="22580" txt_f="22613">: partial pressure of oxygen; SaO</offsets><sub><offsets xml_i="34393" xml_f="34394" txt_i="22613" txt_f="22614">2</offsets></sub><offsets xml_i="34400" xml_f="34431" txt_i="22614" txt_f="22645">: arterial oxygen saturation; V</offsets><sub><offsets xml_i="34436" xml_f="34437" txt_i="22645" txt_f="22646">T</offsets></sub><offsets xml_i="34443" xml_f="34458" txt_i="22646" txt_f="22661">: tidal volume.</offsets></p></sec><sec><title><offsets xml_i="34480" xml_f="34499" txt_i="22663" txt_f="22682">Competing interests</offsets></title><p><offsets xml_i="34510" xml_f="34568" txt_i="22683" txt_f="22741">The authors declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="34590" xml_f="34612" txt_i="22743" txt_f="22765">Authors' contributions</offsets></title><p><offsets xml_i="34623" xml_f="34925" txt_i="22766" txt_f="23068">JWH recruited patients, analysed the data and wrote the manuscript. HJ and HSC helped to recruit patients and analysed the data. SBH and CML recruited patients and interpreted the data. YK designed the study, interpreted the data and wrote the paper. All authors read and approved the final manuscript.</offsets></p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><article-title>Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network</article-title><source>N Engl J Med</source><year>2000</year><volume>342</volume><fpage>1301</fpage><lpage>1308</lpage><pub-id pub-id-type="pmid">10793162</pub-id><pub-id pub-id-type="doi">10.1056/NEJM200005043421801</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>MB</given-names></name><name><surname>Barbas</surname><given-names>CS</given-names></name><name><surname>Medeiros</surname><given-names>DM</given-names></name><name><surname>Magaldi</surname><given-names>RB</given-names></name><name><surname>Schettino</surname><given-names>GP</given-names></name><name><surname>Lorenzi-Filho</surname><given-names>G</given-names></name><name><surname>Kairalla</surname><given-names>RA</given-names></name><name><surname>Deheinzelin</surname><given-names>D</given-names></name><name><surname>Munoz</surname><given-names>C</given-names></name><name><surname>Oliveira</surname><given-names>R</given-names></name><name><surname>Takagaki</surname><given-names>TY</given-names></name><name><surname>Carvalho</surname><given-names>CR</given-names></name></person-group><article-title>Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome</article-title><source>N Engl J Med</source><year>1998</year><volume>338</volume><fpage>347</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">9449727</pub-id><pub-id pub-id-type="doi">10.1056/NEJM199802053380602</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villar</surname><given-names>J</given-names></name><name><surname>Kacmarek</surname><given-names>RM</given-names></name><name><surname>Perez-Mendez</surname><given-names>L</given-names></name><name><surname>Aguirre-Jaime</surname><given-names>A</given-names></name></person-group><article-title>A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial</article-title><source>Crit Care Med</source><year>2006</year><volume>34</volume><fpage>1311</fpage><lpage>1318</lpage><pub-id pub-id-type="pmid">16557151</pub-id><pub-id pub-id-type="doi">10.1097/01.CCM.0000215598.84885.01</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>C</given-names></name><name><surname>Ferrer</surname><given-names>M</given-names></name><name><surname>Roca</surname><given-names>J</given-names></name><name><surname>Torres</surname><given-names>A</given-names></name><name><surname>Hernandez</surname><given-names>C</given-names></name><name><surname>Rodriguez-Roisin</surname><given-names>R</given-names></name></person-group><article-title>Pulmonary gas exchange response to oxygen breathing in acute lung injury</article-title><source>Am J Respir Crit Care Med</source><year>2000</year><volume>161</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">10619793</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ranieri</surname><given-names>VM</given-names></name><name><surname>Suter</surname><given-names>PM</given-names></name><name><surname>Tortorella</surname><given-names>C</given-names></name><name><surname>De Tullio</surname><given-names>R</given-names></name><name><surname>Dayer</surname><given-names>JM</given-names></name><name><surname>Brienza</surname><given-names>A</given-names></name><name><surname>Bruno</surname><given-names>F</given-names></name><name><surname>Slutsky</surname><given-names>AS</given-names></name></person-group><article-title>Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial</article-title><source>JAMA</source><year>1999</year><volume>282</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">10404912</pub-id><pub-id pub-id-type="doi">10.1001/jama.282.1.54</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rouby</surname><given-names>JJ</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Goldstein</surname><given-names>I</given-names></name></person-group><article-title>Selecting the right level of positive end-expiratory pressure in patients with acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>165</volume><fpage>1182</fpage><lpage>1186</lpage><pub-id pub-id-type="pmid">11956065</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brower</surname><given-names>RG</given-names></name><name><surname>Lanken</surname><given-names>PN</given-names></name><name><surname>MacIntyre</surname><given-names>N</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Morris</surname><given-names>A</given-names></name><name><surname>Ancukiewicz</surname><given-names>M</given-names></name><name><surname>Schoenfeld</surname><given-names>D</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name></person-group><article-title>Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome</article-title><source>N Engl J Med</source><year>2004</year><volume>351</volume><fpage>327</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">15269312</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa032193</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Caironi</surname><given-names>P</given-names></name><name><surname>Cressoni</surname><given-names>M</given-names></name><name><surname>Chiumello</surname><given-names>D</given-names></name><name><surname>Ranieri</surname><given-names>VM</given-names></name><name><surname>Quintel</surname><given-names>M</given-names></name><name><surname>Russo</surname><given-names>S</given-names></name><name><surname>Patroniti</surname><given-names>N</given-names></name><name><surname>Cornejo</surname><given-names>R</given-names></name><name><surname>Bugedo</surname><given-names>G</given-names></name></person-group><article-title>Lung recruitment in patients with the acute respiratory distress syndrome</article-title><source>N Engl J Med</source><year>2006</year><volume>354</volume><fpage>1775</fpage><lpage>1786</lpage><pub-id pub-id-type="pmid">16641394</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa052052</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mercat</surname><given-names>A</given-names></name><name><surname>Richard</surname><given-names>JC</given-names></name><name><surname>Vielle</surname><given-names>B</given-names></name><name><surname>Jaber</surname><given-names>S</given-names></name><name><surname>Osman</surname><given-names>D</given-names></name><name><surname>Diehl</surname><given-names>JL</given-names></name><name><surname>Lefrant</surname><given-names>JY</given-names></name><name><surname>Prat</surname><given-names>G</given-names></name><name><surname>Richecoeur</surname><given-names>J</given-names></name><name><surname>Nieszkowska</surname><given-names>A</given-names></name><name><surname>Gervais</surname><given-names>C</given-names></name><name><surname>Baudot</surname><given-names>J</given-names></name><name><surname>Bouadma</surname><given-names>L</given-names></name><name><surname>Brochard</surname><given-names>L</given-names></name></person-group><article-title>Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial</article-title><source>JAMA</source><year>2008</year><volume>299</volume><fpage>646</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">18270353</pub-id><pub-id pub-id-type="doi">10.1001/jama.299.6.646</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meade</surname><given-names>MO</given-names></name><name><surname>Cook</surname><given-names>DJ</given-names></name><name><surname>Guyatt</surname><given-names>GH</given-names></name><name><surname>Slutsky</surname><given-names>AS</given-names></name><name><surname>Arabi</surname><given-names>YM</given-names></name><name><surname>Cooper</surname><given-names>DJ</given-names></name><name><surname>Davies</surname><given-names>AR</given-names></name><name><surname>Hand</surname><given-names>LE</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Thabane</surname><given-names>L</given-names></name><name><surname>Austin</surname><given-names>P</given-names></name><name><surname>Lapinsky</surname><given-names>S</given-names></name><name><surname>Baxter</surname><given-names>A</given-names></name><name><surname>Russell</surname><given-names>J</given-names></name><name><surname>Skrobik</surname><given-names>Y</given-names></name><name><surname>Ronco</surname><given-names>JJ</given-names></name><name><surname>Stewart</surname><given-names>TE</given-names></name></person-group><article-title>Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial</article-title><source>JAMA</source><year>2008</year><volume>299</volume><fpage>637</fpage><lpage>645</lpage><pub-id pub-id-type="pmid">18270352</pub-id><pub-id pub-id-type="doi">10.1001/jama.299.6.637</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>T</given-names></name><name><surname>Suchodolski</surname><given-names>K</given-names></name><name><surname>Schettino</surname><given-names>GP</given-names></name><name><surname>Sedeek</surname><given-names>K</given-names></name><name><surname>Takeuch</surname><given-names>M</given-names></name><name><surname>Kacmarek</surname><given-names>RM</given-names></name></person-group><article-title>Peak volume history and peak pressure-volume curve pressures independently affect the shape of the pressure-volume curve of the respiratory system</article-title><source>Crit Care Med</source><year>2004</year><volume>32</volume><fpage>1358</fpage><lpage>1364</lpage><pub-id pub-id-type="pmid">15187520</pub-id><pub-id pub-id-type="doi">10.1097/01.CCM.0000128573.28173.2E</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Artigas</surname><given-names>A</given-names></name><name><surname>Bernard</surname><given-names>GR</given-names></name><name><surname>Carlet</surname><given-names>J</given-names></name><name><surname>Dreyfuss</surname><given-names>D</given-names></name><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Hudson</surname><given-names>L</given-names></name><name><surname>Lamy</surname><given-names>M</given-names></name><name><surname>Marini</surname><given-names>JJ</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Pinsky</surname><given-names>MR</given-names></name><name><surname>Spragg</surname><given-names>R</given-names></name><name><surname>Suter</surname><given-names>PM</given-names></name></person-group><article-title>The American-European Consensus Conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med</source><year>1998</year><volume>157</volume><fpage>1332</fpage><lpage>1347</lpage><pub-id pub-id-type="pmid">9563759</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>CM</given-names></name><name><surname>Koh</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>W</given-names></name><name><surname>Chin</surname><given-names>JY</given-names></name><name><surname>Shim</surname><given-names>TS</given-names></name><name><surname>Lee</surname><given-names>SD</given-names></name><name><surname>Kim</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Kim</surname><given-names>WD</given-names></name></person-group><article-title>Mechanistic scheme and effect of "extended sigh" as a recruitment maneuver in patients with acute respiratory distress syndrome: a preliminary study</article-title><source>Crit Care Med</source><year>2001</year><volume>29</volume><fpage>1255</fpage><lpage>1260</lpage><pub-id pub-id-type="pmid">11395617</pub-id><pub-id pub-id-type="doi">10.1097/00003246-200106000-00037</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grasso</surname><given-names>S</given-names></name><name><surname>Mascia</surname><given-names>L</given-names></name><name><surname>Del Turco</surname><given-names>M</given-names></name><name><surname>Malacarne</surname><given-names>P</given-names></name><name><surname>Giunta</surname><given-names>F</given-names></name><name><surname>Brochard</surname><given-names>L</given-names></name><name><surname>Slutsky</surname><given-names>AS</given-names></name><name><surname>Marco Ranieri</surname><given-names>V</given-names></name></person-group><article-title>Effects of recruiting maneuvers in patients with acute respiratory distress syndrome ventilated with protective ventilatory strategy</article-title><source>Anesthesiology</source><year>2002</year><volume>96</volume><fpage>795</fpage><lpage>802</lpage><pub-id pub-id-type="pmid">11964585</pub-id><pub-id pub-id-type="doi">10.1097/00000542-200204000-00005</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lachmann</surname><given-names>B</given-names></name></person-group><article-title>Open up the lung and keep the lung open</article-title><source>Intensive Care Med</source><year>1992</year><volume>18</volume><fpage>319</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">1469157</pub-id><pub-id pub-id-type="doi">10.1007/BF01694358</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Medoff</surname><given-names>BD</given-names></name><name><surname>Harris</surname><given-names>RS</given-names></name><name><surname>Kesselman</surname><given-names>H</given-names></name><name><surname>Venegas</surname><given-names>J</given-names></name><name><surname>Amato</surname><given-names>MB</given-names></name><name><surname>Hess</surname><given-names>D</given-names></name></person-group><article-title>Use of recruitment maneuvers and high-positive end-expiratory pressure in a patient with acute respiratory distress syndrome</article-title><source>Crit Care Med</source><year>2000</year><volume>28</volume><fpage>1210</fpage><lpage>1216</lpage><pub-id pub-id-type="pmid">10809308</pub-id><pub-id pub-id-type="doi">10.1097/00003246-200004000-00051</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Halter</surname><given-names>JM</given-names></name><name><surname>Steinberg</surname><given-names>JM</given-names></name><name><surname>Schiller</surname><given-names>HJ</given-names></name><name><surname>DaSilva</surname><given-names>M</given-names></name><name><surname>Gatto</surname><given-names>LA</given-names></name><name><surname>Landas</surname><given-names>S</given-names></name><name><surname>Nieman</surname><given-names>GF</given-names></name></person-group><article-title>Positive end-expiratory pressure after a recruitment maneuver prevents both alveolar collapse and recruitment/derecruitment</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>167</volume><fpage>1620</fpage><lpage>1626</lpage><pub-id pub-id-type="pmid">12615628</pub-id><pub-id pub-id-type="doi">10.1164/rccm.200205-435OC</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>CM</given-names></name><name><surname>Jung</surname><given-names>H</given-names></name><name><surname>Koh</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Shim</surname><given-names>TS</given-names></name><name><surname>Lee</surname><given-names>SD</given-names></name><name><surname>Kim</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Kim</surname><given-names>WD</given-names></name></person-group><article-title>Effect of alveolar recruitment maneuver in early acute respiratory distress syndrome according to antiderecruitment strategy, etiological category of diffuse lung injury, and body position of the patient</article-title><source>Crit Care Med</source><year>2003</year><volume>31</volume><fpage>411</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">12576945</pub-id><pub-id pub-id-type="doi">10.1097/01.CCM.0000048631.88155.39</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Pelosi</surname><given-names>P</given-names></name><name><surname>Suter</surname><given-names>PM</given-names></name><name><surname>Pedoto</surname><given-names>A</given-names></name><name><surname>Vercesi</surname><given-names>P</given-names></name><name><surname>Lissoni</surname><given-names>A</given-names></name></person-group><article-title>Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?</article-title><source>Am J Respir Crit Care Med</source><year>1998</year><volume>158</volume><fpage>3</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">9655699</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Talmor</surname><given-names>D</given-names></name><name><surname>Sarge</surname><given-names>T</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>O'Donnell</surname><given-names>CR</given-names></name><name><surname>Ritz</surname><given-names>R</given-names></name><name><surname>Lisbon</surname><given-names>A</given-names></name><name><surname>Novack</surname><given-names>V</given-names></name><name><surname>Loring</surname><given-names>SH</given-names></name></person-group><article-title>Mechanical ventilation guided by esophageal pressure in acute lung injury</article-title><source>N Engl J Med</source><year>2008</year><volume>359</volume><fpage>2095</fpage><lpage>2104</lpage><pub-id pub-id-type="pmid">19001507</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa0708638</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borges</surname><given-names>JB</given-names></name><name><surname>Okamoto</surname><given-names>VN</given-names></name><name><surname>Matos</surname><given-names>GF</given-names></name><name><surname>Caramez</surname><given-names>MP</given-names></name><name><surname>Arantes</surname><given-names>PR</given-names></name><name><surname>Barros</surname><given-names>F</given-names></name><name><surname>Souza</surname><given-names>CE</given-names></name><name><surname>Victorino</surname><given-names>JA</given-names></name><name><surname>Kacmarek</surname><given-names>RM</given-names></name><name><surname>Barbas</surname><given-names>CS</given-names></name><name><surname>Carvalho</surname><given-names>CR</given-names></name><name><surname>Amato</surname><given-names>MB</given-names></name></person-group><article-title>Reversibility of lung collapse and hypoxemia in early acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med</source><year>2006</year><volume>174</volume><fpage>268</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">16690982</pub-id><pub-id pub-id-type="doi">10.1164/rccm.200506-976OC</pub-id></citation></ref></ref-list></back></article>